Pantoprazolum [Inn-Latin] en es it fr

Pantoprazolum [Inn-Latin] Brand names, Pantoprazolum [Inn-Latin] Analogs

Pantoprazolum [Inn-Latin] Brand Names Mixture

  • No information avaliable

Pantoprazolum [Inn-Latin] Chemical_Formula


Pantoprazolum [Inn-Latin] RX_link

Pantoprazolum [Inn-Latin] fda sheet

Pantoprazolum_[Inn-Latin] FDA

Pantoprazolum [Inn-Latin] msds (material safety sheet)

Pantoprazolum_[Inn-Latin] MSDS

Pantoprazolum [Inn-Latin] Synthesis Reference

No information avaliable

Pantoprazolum [Inn-Latin] Molecular Weight

383.371 g/mol

Pantoprazolum [Inn-Latin] Melting Point

Because of gradual degradation of pantoprazole sodium during heating, the melting point cannot be determined.

Pantoprazolum [Inn-Latin] H2O Solubility

Freely soluble in water.

Pantoprazolum [Inn-Latin] State


Pantoprazolum [Inn-Latin] LogP


Pantoprazolum [Inn-Latin] Dosage Forms

Tablet (enteric-coated)

Pantoprazolum [Inn-Latin] Indication

Short-term (up to 16 weeks) treatment of erosive esophagitis.

Pantoprazolum [Inn-Latin] Pharmacology

Pantoprazole is a substituted benzimidazole indicated for the short-term treatment (up to 16 weeks) in the healing and symptomatic relief of erosive esophagitis. Pantoprazole is a proton pump inhibitor (PPI) that suppresses the final step in gastric acid production.

Pantoprazolum [Inn-Latin] Absorption

Pantoprazole is well absorbed; it undergoes little first-pass metabolism resulting in an absolute bioavailability of approximately 77%.

Pantoprazolum [Inn-Latin] side effects and Toxicity

No information avaliable

Pantoprazolum [Inn-Latin] Patient Information

Patients should be cautioned that PROTONIX Delayed-Release Tablets should not be split, crushed or chewed. The tablets should be swallowed whole, with or without food in the stomach. Concomitant administration of antacids does not affect the absorption of pantoprazole.

Pantoprazolum [Inn-Latin] Organisms Affected

Humans and other mammals